Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Basket trial concept to independently and simultaneously assess the effects of the
association of atezolizumab + BDB001 + radiotherapy in multiple solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Institut Bergonié
Collaborators:
Immune Design National Cancer Institute, France Roche Pharma AG Seven and Eight Biopharmaceuticals Inc